Vividion Therapeutics is a biotechnology company that is focused on developing small molecule drugs for the treatment of serious diseases. The company's proprietary platform enables the discovery of novel drug candidates by identifying and targeting proteins that are involved in disease pathways. Vividion's technology has the potential to transform drug discovery by enabling the development of drugs for targets that were previously considered undruggable. The company was founded in 2016 and is headquartered in San Diego, California.